Aldeyra Therapeutics (ALDX) Hits Bullish Run with Phase 3 Trial Success for Reproxalap in Allergic Conjunctivitis
Shares of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) experienced a significant increase of 8.64% in pre-market trading on Thursday. This surge […]
